Open AccessACTR-04. RESULTS OF THE INTERIM ANALYSIS OF THE EORTC RANDOMIZED PHASE III CATNON TRIAL ON CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN ANAPLASTIC GLIOMA WITHOUT 1p/19q CO-DELETION, AN INTERGROUP TRIAL
Author(s) -
Martin J. van den Bent,
Michael A. Vogelbaum,
Sara Erridge,
Anne Nowak,
Marc Sanson,
Alba A. Brandes,
Wolfgang Wick,
Paul M. Clément,
Francois Baurain,
Warren Mason,
Helen Wheeler,
Olivier Chinot,
Michael Weller,
Vassilis Golfinopoulos,
Ken Aldape,
Hendrikus J. Dubbink,
Pieter Wesseling,
Thierry Gorlia,
Brigitta G. Baumert,
Johan M. Kros
Publication year - 2016
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/now212.003
Subject(s) - temozolomide , interim analysis , medicine , oncology , glioma , adjuvant , clinical endpoint , randomized controlled trial , chemotherapy , cancer research
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom